Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ursula Gundert-Remy

Showing results (21-30 of 267) with videos related to

Pageof 27
Sort By:
Basic & Clinical Pharmacology & Toxicology|March 1, 2005
The use of in vitro data in risk assessmentUlrike Bernauer, Axel Oberemm, Stephan Madle, et al.
Regulatory Toxicology and Pharmacology : RTP|May 3, 2003
Immunochemical analysis of cytochrome P450 variability in human leukapheresed samples and its consequences for the risk assessment processUlrike Bernauer, Henrik Garritsen, Barbara Heinrich-Hirsch, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 28, 2002
In silico prediction of ADME and pharmacokinetics. Report of an expert meeting organised by COST B15Alan Boobis, Ursula Gundert-Remy, Pierre Kremers, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|July 20, 2018
[Recording and assessment of medication errors : Experience of the Drug Commission of the German Medical Association]Ursula Köberle, Thomas Stammschulte, Ursula Gundert-Remy, et al.
Toxicology Letters|December 11, 2007
Exposure-triggered reproductive toxicity testing under the REACH legislation: a proposal to define significant/relevant exposureUlrike Bernauer, Gerhard Heinemeyer, Barbara Heinrich-Hirsch, et al.
European Journal of Clinical Pharmacology|July 15, 2015
Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990-2012Thomas Stammschulte, Wolf-Dieter Ludwig, Bernd Mühlbauer, et al.
Critical Reviews in Toxicology|August 8, 2008
Local kinetics and dynamics of xenobioticsOlavi Pelkonen, Jaime Kapitulnik, Ursula Gundert-Remy, et al.
Toxicology Letters|February 18, 2006
Characterisation of the xenobiotic-metabolizing Cytochrome P450 expression pattern in human lung tissue by immunochemical and activity determinationUlrike Bernauer, Barbara Heinrich-Hirsch, Mario Tönnies, et al.
Journal of Hazardous Materials|December 14, 2005
The AETL methodology as a potential solution to current challenges associated with the development and use of acute exposure levels in Seveso II applicationsMaureen Wood, Annick Pichard, Ursula Gundert-Remy, et al.
Expert Opinion on Therapeutic Targets|June 18, 2009
Effects of pharmaceuticals and other active chemicals at biological targets: mechanisms, interactions, and integration into PB-PK/PD modelsJaime Kapitulnik, Olavi Pelkonen, Ursula Gundert-Remy, et al.
Pageof 27

Showing results (21-30 of 267) with videos related to

Sort By:
Pageof 27
Basic & Clinical Pharmacology & Toxicology|March 1, 2005
The use of in vitro data in risk assessmentUlrike Bernauer, Axel Oberemm, Stephan Madle, et al.
Regulatory Toxicology and Pharmacology : RTP|May 3, 2003
Immunochemical analysis of cytochrome P450 variability in human leukapheresed samples and its consequences for the risk assessment processUlrike Bernauer, Henrik Garritsen, Barbara Heinrich-Hirsch, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 28, 2002
In silico prediction of ADME and pharmacokinetics. Report of an expert meeting organised by COST B15Alan Boobis, Ursula Gundert-Remy, Pierre Kremers, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|July 20, 2018
[Recording and assessment of medication errors : Experience of the Drug Commission of the German Medical Association]Ursula Köberle, Thomas Stammschulte, Ursula Gundert-Remy, et al.
Toxicology Letters|December 11, 2007
Exposure-triggered reproductive toxicity testing under the REACH legislation: a proposal to define significant/relevant exposureUlrike Bernauer, Gerhard Heinemeyer, Barbara Heinrich-Hirsch, et al.
European Journal of Clinical Pharmacology|July 15, 2015
Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990-2012Thomas Stammschulte, Wolf-Dieter Ludwig, Bernd Mühlbauer, et al.
Critical Reviews in Toxicology|August 8, 2008
Local kinetics and dynamics of xenobioticsOlavi Pelkonen, Jaime Kapitulnik, Ursula Gundert-Remy, et al.
Toxicology Letters|February 18, 2006
Characterisation of the xenobiotic-metabolizing Cytochrome P450 expression pattern in human lung tissue by immunochemical and activity determinationUlrike Bernauer, Barbara Heinrich-Hirsch, Mario Tönnies, et al.
Journal of Hazardous Materials|December 14, 2005
The AETL methodology as a potential solution to current challenges associated with the development and use of acute exposure levels in Seveso II applicationsMaureen Wood, Annick Pichard, Ursula Gundert-Remy, et al.
Expert Opinion on Therapeutic Targets|June 18, 2009
Effects of pharmaceuticals and other active chemicals at biological targets: mechanisms, interactions, and integration into PB-PK/PD modelsJaime Kapitulnik, Olavi Pelkonen, Ursula Gundert-Remy, et al.
Pageof 27